Landscape Capital Management’s Estrella Immunopharma Warrant ESLAW Stock Holding History

Landscape Capital Management’s Portfolio ESLAW Stock Details ESLAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-13,682	Closed	-$684	–	799
2025 Q4	$684	Hold	13,682	–	–	﹤0.01%	695
2025 Q3	$709	Hold	13,682	–	–	﹤0.01%	603
2025 Q2	$650	Hold	13,682	–	–	﹤0.01%	636
2025 Q1	$1.05K	Hold	13,682	–	–	﹤0.01%	611
2024 Q4	$1.26K	Hold	13,682	–	–	﹤0.01%	696
2024 Q3	$880	Hold	13,682	–	–	﹤0.01%	637
2024 Q2	$944	Hold	13,682	–	–	﹤0.01%	683
2024 Q1	$908	Hold	13,682	–	–	﹤0.01%	710
2023 Q4	$410	Hold	13,682	–	–	﹤0.01%	820
2023 Q3	$3.4K	Hold	13,682	–	–	﹤0.01%	470
2023 Q2	$759	Hold	13,682	–	–	﹤0.01%	529
2023 Q1	$1.4K	Hold	13,682	–	–	﹤0.01%	609
2022 Q4	$711	Buy	+13,682	New	+$1.14K	﹤0.01%	828

Other funds holding ESLAW

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

RSWM

Robertson Stephens Wealth Management San Francisco, California $4.06B AUM 32.22% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

SIA

SkyView Investment Advisors Shrewsbury, New Jersey $743M AUM 17.91% 1-Year Est. Return

YCM

Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return

Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Landscape Capital Management's ESLAW Position: Q1 2026 in Review

Landscape Capital Management sold out of Estrella Immunopharma Warrant (ESLAW) in Q1 2026, closing a stake of 13,682 shares — an estimated $684 sold.

Landscape Capital Management first reported a position in ESLAW in Q4 2022 and held it in 13 quarters. The position peaked at $3.4K in Q3 2023. 8 funds tracked by Wall St. Rank hold ESLAW as of Q1 2026.

Landscape Capital Management reported no remaining Estrella Immunopharma Warrant position as of Q1 2026 after selling out during the quarter.
Landscape Capital Management sold 13,682 Estrella Immunopharma Warrant shares in Q1 2026, an estimated $684.
Landscape Capital Management first reported a position in Estrella Immunopharma Warrant in Q4 2022 and held it in 13 quarters.
Landscape Capital Management's Estrella Immunopharma Warrant position peaked at $3.4K in Q3 2023.
8 funds tracked by Wall St. Rank held Estrella Immunopharma Warrant as of Q1 2026.

Based on Landscape Capital Management's 13F filing for Q1 2026, filed 12 May 2026.